Product Code: ETC7808075 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Kenya NTRK Fusion Gene Positive Advanced Solid Tumor Market Overview |
3.1 Kenya Country Macro Economic Indicators |
3.2 Kenya NTRK Fusion Gene Positive Advanced Solid Tumor Market Revenues & Volume, 2021 & 2031F |
3.3 Kenya NTRK Fusion Gene Positive Advanced Solid Tumor Market - Industry Life Cycle |
3.4 Kenya NTRK Fusion Gene Positive Advanced Solid Tumor Market - Porter's Five Forces |
3.5 Kenya NTRK Fusion Gene Positive Advanced Solid Tumor Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Kenya NTRK Fusion Gene Positive Advanced Solid Tumor Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Kenya NTRK Fusion Gene Positive Advanced Solid Tumor Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis of genetic testing for NTRK fusion gene positive tumors |
4.2.2 Advancements in precision medicine and targeted therapies for solid tumors |
4.3 Market Restraints |
4.3.1 Limited access to advanced diagnostic tools and treatments in certain regions of Kenya |
4.3.2 High cost associated with targeted therapies for NTRK fusion gene positive tumors |
5 Kenya NTRK Fusion Gene Positive Advanced Solid Tumor Market Trends |
6 Kenya NTRK Fusion Gene Positive Advanced Solid Tumor Market, By Types |
6.1 Kenya NTRK Fusion Gene Positive Advanced Solid Tumor Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Kenya NTRK Fusion Gene Positive Advanced Solid Tumor Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Kenya NTRK Fusion Gene Positive Advanced Solid Tumor Market Revenues & Volume, By Therapeutics, 2021- 2031F |
6.1.4 Kenya NTRK Fusion Gene Positive Advanced Solid Tumor Market Revenues & Volume, By Diagnostics, 2021- 2031F |
6.2 Kenya NTRK Fusion Gene Positive Advanced Solid Tumor Market, By End-User |
6.2.1 Overview and Analysis |
6.2.2 Kenya NTRK Fusion Gene Positive Advanced Solid Tumor Market Revenues & Volume, By Hospitals and Clinics, 2021- 2031F |
6.2.3 Kenya NTRK Fusion Gene Positive Advanced Solid Tumor Market Revenues & Volume, By Cancer Centers, 2021- 2031F |
6.2.4 Kenya NTRK Fusion Gene Positive Advanced Solid Tumor Market Revenues & Volume, By Others, 2021- 2031F |
7 Kenya NTRK Fusion Gene Positive Advanced Solid Tumor Market Import-Export Trade Statistics |
7.1 Kenya NTRK Fusion Gene Positive Advanced Solid Tumor Market Export to Major Countries |
7.2 Kenya NTRK Fusion Gene Positive Advanced Solid Tumor Market Imports from Major Countries |
8 Kenya NTRK Fusion Gene Positive Advanced Solid Tumor Market Key Performance Indicators |
8.1 Number of healthcare facilities offering genetic testing for NTRK fusion gene positive tumors |
8.2 Percentage of patients diagnosed with NTRK fusion gene positive tumors out of total solid tumor cases |
8.3 Rate of adoption of targeted therapies for NTRK fusion gene positive tumors |
9 Kenya NTRK Fusion Gene Positive Advanced Solid Tumor Market - Opportunity Assessment |
9.1 Kenya NTRK Fusion Gene Positive Advanced Solid Tumor Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Kenya NTRK Fusion Gene Positive Advanced Solid Tumor Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Kenya NTRK Fusion Gene Positive Advanced Solid Tumor Market - Competitive Landscape |
10.1 Kenya NTRK Fusion Gene Positive Advanced Solid Tumor Market Revenue Share, By Companies, 2024 |
10.2 Kenya NTRK Fusion Gene Positive Advanced Solid Tumor Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |